WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report) saw unusually-high trading volume on Wednesday . 130,387 shares changed hands during mid-day trading, an increase of 82% from the previous session’s volume of 71,527 shares.The stock last traded at $13.7380 and had previously closed at $13.78.
Analyst Ratings Changes
Separately, Zacks Research raised WuXi Biologics (Cayman) to a “hold” rating in a research note on Friday, August 28th. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, WuXi Biologics (Cayman) currently has a consensus rating of “Hold”.
Check Out Our Latest Research Report on WuXi Biologics (Cayman)
WuXi Biologics (Cayman) Price Performance
About WuXi Biologics (Cayman)
WuXi Biologics (Cayman) is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company provides integrated services to pharmaceutical and biotechnology customers across the development cycle, from early-stage discovery and preclinical research through clinical development, regulatory support and commercial manufacturing.
Its capabilities include the development and production of monoclonal antibodies, recombinant proteins, vaccines, antibody-drug conjugates and other biologic modalities.
Further Reading
- Five stocks we like better than WuXi Biologics (Cayman)
- Viking’s Obesity Edge May Be Staying Power, Not Weight Loss
- Gold Defied the Fed’s Rate Hike—These 3 Plays Stand Out
- Thor Industries Is Boring—And That May Be Its Biggest Advantage
- Full Throttle: Kratos and GE Fire Up a Next-Gen Defense Engine
Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.
